Health Care Policy and Research reported that the absolute number of hospital stays in the United States with CDI increased fourfold from 1993 to 2009. 3 Similarly, a nationwide multicenter study in Korea reported that the incidence of CDI increased significantly from 2004 (1.7 cases/1,000 adult admissions) to 2008 (2.7 cases/1,000 adult admissions). 4 Furthermore, the prevalence of community-acquired CDI and hospital-acquired CDI, without recent exposure to antibiotics, continues to rise. 5, 6 Therefore, CDI is perceived as a significant burden on the healthcare system.
Major risk factors for CDI include systemic antibiotic exposure, prolonged length of hospital stay, comorbidities such as chronic kidney disease, inflammatory bowel disease, immunodeficiency and immunosuppression, hypervirulent strains, and old age (≥65 years). 5, 7, 8 Most hospital-acquired CDI occur in elderly patients due to a high burden of chronic comorbidities, frequent use of antibiotics, more health care exposure, and biological changes associated with aging. 2, 9 However, the number of studies that compare young and elderly patients with CDI are limited.
In the current issue of Korean Journal of Gastroenterology, Lee et al. 10 compared clinical characteristics and outcomes between young and elderly patients hospitalized with CDI.
They enrolled a total of 225 patients with hospital-acquired CDI and grouped them by age (young ＜65 years, elderly ≥ 65 years). In this study, the elderly group (68%) was more frequently affected by CDI compared with the younger group (32%). According to the 2010 clinical practice guidelines for CDI in adults, the severity of CDI can be defined by leukocytosis and increased serum creatinine levels. 11 In another recent study, which compared 52 CDI patients with 150
non-CDI patients among elderly (＞60 years) hospitalized pa-
The Korean Journal of Gastroenterology tients, the authors reported that increased serum creatinine levels due to dehydration or inadequate renal perfusion were independently associated with CDI. 1 In the study by Lee et al., 10 renal failure did not differ significantly between the elderly and young patient groups; however, leukocytosis, hypoalbuminemia, and right colon involvement were more prevalent in the elderly patients who also had a higher mean severity score. According to the results of a previous study that analyzed 70 patients (＞80 years) with CDI, higher white blood cell counts were independently associated with treatment failure. 12 The results of Lee et al. 10 showed that the failure of first-line treatment was also more common in the elderly group (37.9% vs. 23.6%, p=0.034). They reported that old age, leukocytosis, and hypoalbuminemia were the factors associated with first-line treatment failure by univariate analy- ins A and B. 13 In a previous prospective study, the hypervirulent strain was shown to significantly increase the 30-day mortality rate after the age of 60 years, which further increased in patients above the age of 80 years. 14 These factors lead to poor clinical outcomes such as increased disease severity, susceptibility to infection and recurrence, decreased response to treatment, and death in advanced age. 2 Contrastingly, there are studies which show that old age is not an independent risk factor for worse disease outcomes for patients with CDI. 15, 16 In the study by Lee et al., 10 there
were no significant differences in recurrence (15.0% vs. between the elderly and young patient groups. These conflicting findings may be due to differences in age cut-off, differences of the strain of C. difficile, which was not analyzed by Lee et al., 10 the number of patients enrolled in the study, and the lack of adjustment for potential confounding factors influencing the retrospective analysis. Therefore, these limitations must be considered when interpreting the findings of Lee et al. 10 Regardless of whether aging affects the outcome of CDI, advanced age may promote the severity of CDI as the mortality rate in elderly patients (≥ 65 years) with CDI is approximately 92%.
